Brief Research Report: Serum clara cell 16 kDa protein levels are increased in patients hospitalized for severe SARS-CoV-2 or sepsis infectionArticle Published on 2022-10-132022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 바이오마커, [키워드] age Anti-inflammatory Biomarker case-control study CC16 Cell cell damage chronic pulmonary diseases Concentration disease Diseases ELISA epithelial epithelial cell epithelial cell damage Evidence expressed healthy Increased Infection Infectious disease kDa Lungs Non-pulmonary patients hospitalized patients treated Platelet positively correlated previous study Protein protein level SARS-CoV-2 Sepsis Serum level severe infections severe SARS-CoV-2 significantly increased subjects were measured [DOI] 10.3389/fimmu.2022.1037115 PMC 바로가기
Prepandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired AdultsArticle Published on 2022-10-042022-11-15 Journal: Neurology [Category] 바이오마커, [키워드] 95% CI accelerate Acidic adjust age Alzheimer disease analyses Analysis association Biomarker Biomarkers change changes Clinical prognosis Clinicians Cohort cortical COVID-19 CSF Disease progression driven by expressed family greater HADS Identifier IL-6 Increased independent interleukin-6 investigated Linear regression model majority marker medication MRI multivariable myeloid cell Neuroinflammation Neuropsychiatric Older pandemic participant Participants pathophysiology performed pet protein levels receptor retrospective risk scale Sex smoking Sociodemographic factor Stress stressors structures subset Symptom tested triggering variable women [DOI] 10.1212/WNL.0000000000200948 PMC 바로가기
Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020-October 2021Article Published on 2022-10-032022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] Alaska B.1.617.2 B.1.617.2 (Delta) coronavirus 2 coronavirus disease COVID-19 death Delta delta variant higher odd Increased Mortality mortality risk Period Person predominant respiratory risk SARS-CoV-2 symptomatic vaccination virulence [DOI] 10.1093/cid/ciac530 PMC 바로가기
Increased symptom severity in adults and adolescents admitting to an inpatient psychiatric hospital during the COVID-19 pandemicResearch article Published on 2022-10-012022-10-05 Journal: Psychiatry research [Category] 진단, [키워드] Admission Adolescent Adult Anxiety children coronavirus disease-2019 COVID COVID-19 COVID-19 pandemic Depression disease dysregulation Effect effort emotional examined GAD-7 help hospital ideation identify Increased Inpatient less Level measure mental health mental illness nightmare Outbreaks pandemic PHQ-9 Psychiatric psychiatry reported significantly higher sleep quality Substance use symptom severity while [DOI] 10.1016/j.psychres.2022.114758 [Article Type] Research article
Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroidsArticle Published on 2022-10-012022-11-15 Journal: Urologic oncology [Category] COVID19(2023년), SARS, 진단, [키워드] Administered affected Anti-SARS-CoV-2 S antibody Antibody Response Antibody titer BNT162b2 mRNA vaccine Castration-resistant conducted cross-sectional Diagnosis evaluate humoral Humoral response IgG Immunoglobulin Increased mRNA vaccination Patient Prostate cancer Protein PSARS-CoV-2 SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2 vaccine second dose significantly significantly lower statistically steroid Steroids the antibody response the receptor-binding domain titers of IgG Treatment Vaccine [DOI] 10.1016/j.urolonc.2022.07.015 PMC 바로가기
Increased respiratory dead space could associate with coagulation activation and poor outcomes in COVID-19 ARDSResearch article Published on 2022-10-012022-10-05 Journal: Journal of critical care [Category] 바이오마커, [키워드] Activation APACHE II ARDS Coagulation correlated COVID-19 COVID-19 patients Critically ill D-dimer D-dimer level determine discharge discharged enrolled help identify Increased Invasive mechanical ventilation less likelihood material measurement mechanical ventilation outcome outcomes P/F ratio Patient patients with COVID-19 performed Pneumonia primary endpoint Respiratory dead space Respiratory system Result static compliance subgroup of patient supported volumetric Volumetric capnography [DOI] 10.1016/j.jcrc.2022.154095 [Article Type] Research article
Increased household transmission and immune escape of the SARS-CoV-2 Omicron compared to Delta variantsArticle Published on 2022-09-292022-11-16 Journal: Nature Communications [Category] SARS, 변종, [키워드] 95% CI Contact Contact tracing Critical Delta delta variant groups growth household contact household transmission Immune escape Increased independent Infection lower risk omicron public health risk SAR SARS-CoV-2 secondary attack rate Spread susceptibility the epidemic the mean the SARS-CoV-2 Transmissibility understanding vaccination variant variants [DOI] 10.1038/s41467-022-33233-9 PMC 바로가기
Increased percentage of apoptotic and CTLA-4 (CD152) expressing cells in CD4+/CD8+ cells in COVID-19 patientsArticle Published on 2022-09-232022-11-15 Journal: Medicine [Category] 바이오마커, 치료제, [키워드] addition analyzed Apoptosis apoptotic apoptotic cell association blood cell C-reactive protein can be used CD4+ cell CD8+ cell Cell cell count cells characterized Chest CT Clinical severity confirmed case correlated correlation COVID-19 COVID-19 case COVID-19 patient COVID-19 patients CRP CTLA-4 cytotoxic T-lymphocyte antigen-4 detect Diagnosis diagnostic Dyspnea eosinophil expressing expression ferritin flow cytometry healthy control healthy volunteer In-patients Increased Infectious disease lymphocyte Lymphocyte count lymphopenia neutrophil Patient patients Platelet proportion reduced severity significant difference significantly therapeutic targets Total up-regulated WBCs while white with COVID-19 [DOI] 10.1097/MD.0000000000030650 PMC 바로가기
Management of dermatomyositis patients amidst the COVID-19 pandemic: Two case reportsArticle Published on 2022-09-232022-11-15 Journal: Medicine [Category] SARS, 치료제, [키워드] Anti-inflammatory therapy anti-inflammatory treatment anticoagulation Antiviral treatment Case report Characteristics Chest China coronavirus coronavirus disease cough COVID-19 COVID-19 infection dermatomyositis diagnosed diagnosed with COVID-19 Diagnosis discharged Diseases effective Epidemic Fever glucocorticoid Increased infected with COVID-19 Interstitial lung disease laboratory result male management negative PCR test Oxygen therapy pathogenic Patient patients with COVID-19 plasma Prophylactic real-time reverse-transcriptase polymerase-chain-reaction repeated RT-PCR SARS-CoV-2 Shortness of breath Spread Symptom the SARS-CoV-2 virus therapy Treatment Wuhan [DOI] 10.1097/MD.0000000000030634 PMC 바로가기
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infectionArticle Published on 2022-09-222022-11-15 Journal: Vaccine [Category] SARS, 진단, [키워드] Antibody Response association baseline characteristics binding domain booster booster dose collected Comorbidity COVID-19 dose Factor hcp healthcare personnel Immunity Increased inverse correlation mRNA BNT162b2 vaccine mRNA vaccine NAb NAb titer NAb titers Neutralizing antibodies neutralizing antibody of BNT162b2 Sample SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 receptor second dose serum sample study period tested vaccine dose women [DOI] 10.1016/j.vaccine.2022.08.031 PMC 바로가기